Evidence map›Paper›PMID 16443705›Full record

ArticleThorax2006

Inhaled corticosteroids and decline of lung function in community residents with asthma.

P Lange, H Scharling, C S Ulrik, J Vestbo

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Thorax, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03207620 (Interrelation Between Bronchial Asthma and Smoking), which is not on this map. Cited by 31 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 2 pooled it
7.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03207620 completednot on this mapstarted 2018, after this paper: background citation

Interrelation Between Bronchial Asthma and Smoking

TypeobservationalSponsorAssiut UniversityRan2018 to 2021Enrolled117ConditionsBronchial AsthmaArmsusing serum periostin and eotaxin-2 level, airway corticosteroid sensitivity
3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 2 syntheses or guidelines pooled it, 129 citations in OpenAlex.

  1. Does the use of inhaled corticosteroids in asthma benefit lung function in the long-term? A systematic review and meta-analysis.European respiratory review : an official journal of the European Respiratory Society · 2021
    Pooled it
  2. Guideline
  3. Rhinovirus-16 induced temporal interferon responses in nasal epithelium links with viral clearance and symptoms.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2019
    Trial
  4. Trial
  5. Article
  6. Article
  7. Association of demographic variables and smoking habits with the severity of lung function in adult smokers.Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences · 2022
    Article
  8. Article
  9. Review
  10. Article
  11. MicroRNAs as Biomarkers in Corticosteroid-Resistant/Neutrophilic Asthma: Still a Long Way to Go!American journal of respiratory and critical care medicine · 2020
    Article
  12. FEVThe World Allergy Organization journal · 2020
    Article
  13. Review
  14. Determinants of airflow limitation in Danish adults - findings from the Health2006 cohort.International journal of chronic obstructive pulmonary disease · 2019
    Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

P LangeDepartment of Cardiology and Respiratory Diseases, Hvidovre University Hospital, DK-2650 Hvidovre, Denmark. peter.lange@hh.hosp.dk
H Scharling
C S Ulrik
J Vestbo
Hvidovre Hospital · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundInhaled corticosteroids (ICS) constitute the cornerstone of treatment for asthma. Many studies have reported beneficial short term effects of these drugs, but there are few data on the long term effects of ICS on the decline in forced expiratory volume in 1 second (FEV(1)). This study was undertaken to determine whether adults with asthma treated with ICS have a less pronounced decline in FEV(1) than those not treated with ICS.

methodsTwo hundred and thirty four asthmatic individuals from a longitudinal epidemiological study of the general population of Copenhagen, Denmark were divided into two groups; 44 were treated with ICS and 190 were not treated with ICS. The annual decline in FEV(1) was measured over a 10 year follow up period.

resultsThe decline in FEV(1) in the 44 patients receiving ICS was 25 ml/year compared with 51 ml/year in the 190 patients not receiving this treatment (p<0.001). The linear regression model with ICS as the variable of interest and sex, smoking, and wheezing as covariates showed that treatment with ICS was associated with a less steep decline in FEV(1) of 18 ml/year (p = 0.01). Adjustment for additional variables including age, socioeconomic status, body mass index, mucus hypersecretion, and use of other asthma medications did not change these results.

conclusionsTreatment with ICS is associated with a significantly reduced decline in ventilatory function.

Indexed as

Administration, InhalationAdrenal Cortex HormonesAsthmaDisease ProgressionFemaleForced Expiratory VolumeHumansMaleMiddle AgedVital CapacityAdrenal Cortex Hormones

Identifiers

PMID16443705
PMCPMC2104582
OpenAlexW2130554733

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.